Daniel Barocas Archives
Jan. 23, 2020—A five-year follow-up study of more than 2,000 U.S. men who received prostate cancer treatment is creating a road map for future patients regarding long-term bowel, bladder and sexual function in order to clarify expectations and enable men to make informed choices about care.
Jan. 31, 2019—Daniel Barocas, MD, MPH, associate professor of Urology, is being recognized with a national award from the Society of Urologic Oncology (SUO) for his efforts to develop urologic cancer quality measures.
May. 18, 2017—Daniel Barocas, M.D., associate professor of Urologic Surgery, recently received the Society of Urologic Oncology’s (SUO) Young Investigator Award at the group’s 2017 annual meeting in Boston.
Mar. 21, 2017—Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association (JAMA).
Jun. 18, 2015—A new study led by Vanderbilt University Medical Center investigators found new diagnoses of prostate cancer in the U.S. declined 28 percent in the year following the draft recommendation from the United States Preventive Services Task Force against routine PSA screening for men.
Aug. 30, 2012—Racial differences exist in quality surgical care, new research from VICC finds.